SPPI News and Press, Spectrum Pharmaceuticals Inc. From 08/11/22

Spectrum Pharma ( NASDAQ: SPPI ) is trading ~9% higher after the company said the U.S. Food and Drug Administration completes re-inspection of drug substance manufacturing facility for eflapegrastim to treat chemotherapy-induced neutropenia. "The completion o...

Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2022 Earnings Conference Call August 11, 2022 08:30 A.M. ET Company Participants Michael Grabow - SVP, Corporate Strategy and Operations Thomas J. Riga - President and CEO Francois J. Lebel - EVP and CMO Nora E. Brenna...

Spectrum Pharmaceuticals press release ( NASDAQ: SPPI ): Q2 GAAP EPS of -$0.17 misses by $0.02 . The company’s cash, cash equivalents and marketable securities balance was approximately $68M at June 30, 2022, which provides for a cash runway into 2023. For...

Eflapegrastim BLA under FDA review; PDUFA date September 9, 2022 FDA completes re-inspection of drug substance manufacturing facility for eflapegrastim Poziotinib NDA under FDA review with ODAC meeting on September 22, 2022 Management to host webcast and confer...

Spectrum Pharmaceuticals ( NASDAQ: SPPI ) is scheduled to announce Q2 earnings results on Thursday, August 11th, before market open. The consensus EPS Estimate is -$0.10 (+60.0% Y/Y) and the consensus Revenue Estimate is $0M Over the last 2 years, SPPI has beaten EPS...

Major earnings expected before the bell on Thursday include: Arrival ( ARVL ) Brookfield Asset Management ( BAM ) Cardinal Health ( CAH ) Hanesbrands ( HBI ) Himax Technologies ( HIMX ) For further details see: Notable earnings before Thur...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2022 financial results and provide a corporate update on Thursday, August 11, 2022 at 8:3...

The definition of penny stocks is shares of companies trading below $5. But some of the most active traders in the stock market today focus on far cheaper issuers daily. Today we look at a few of the lowest-priced companies gaining attention. While there are many risks involved with stocks ...

Bluebird Bio (BLUE), Clovis Oncology (NASDAQ:CLVS) and Chimerix (CMRX) are trading lower in the morning hours Thursday after Truist said that the three biotechs are at the risk of running out of cash within the next six months. The analysis of 118 companies developing cancer medications exclu...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in two upcoming investor conferences: A fireside chat presentation at the Jefferies Healthcare Conference in Ne...